Literature DB >> 24029098

MRI features of spinal solitary fibrous tumors. A report of two cases and literature review.

G Mariniello1, M Napoli, C Russo, F Briganti, A Giamundo, F Maiuri, M L Del Basso De Caro.   

Abstract

Spinal solitary fibrous tumors (SFT) are very rare neoplasms occurring in the spinal canal, with only 38 cases reported in ten years since the first description. We describe two cases of SFT of the spine and review 33 well-documented cases in the literature to define distinctive radiological and surgical features raising the suspicion of a spinal SFT before histological verification. A 67-year-old man with cervical myeloradiculopathy had a large extramedullary tumor of the cervical spinal canal extending from C4 to C7. On MRI the tumor was isointense on T1-sequences and hypointense on T2-sequences, and had marked contrast enhancement. At surgery, the tumor was intradural extramedullary, with no dural or root attachment, but it was adherent to the cord. Complete tumor removal was achieved with good outcome. A 75-year-old man with progressive thoracic myelopathy had an intramedullary tumor at C6 and C7 level, which was hypointense on T1- and T2-weighted images of MRI. At surgery, the tumor was intramedullary and strongly adherent to the cord; it was successfully removed. Both tumors were composed of elongated cells with a collagen-matrix background. Immunohistochemical staining was positive for vimentin, CD34, and bcl-2, and negative for EMA and S-100 protein. A careful analysis of our own and the other reported cases of spinal SFTs may disclose some peculiar features of this rare tumor. A spinal intramedullary or extramedullary tumor, hypointense on T2-weighted images of MRI, which intraoperatively shows hard consistency, scarce vascularization, no nerve root involvement, no or weak dural attachment, absence of arachnoidal interface, and adherence to the spinal cord may suggest the diagnosis of SFT.

Entities:  

Year:  2012        PMID: 24029098     DOI: 10.1177/197140091202500516

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  7 in total

1.  O2-O3 chemodiscolysis: How much, how long? Retrospective outcome evaluation of different treatment sessions in partially-responder patients.

Authors:  Federico Bruno; Nicola Carboni; Pierpaolo Palumbo; Francesco Arrigoni; Marco Varrassi; Antonio Izzo; Nadia Catallo; Ernesto Di Cesare; Carlo Masciocchi; Alessandra Splendiani; Andrea Giovagnoni; Antonio Barile
Journal:  Interv Neuroradiol       Date:  2021-09-13       Impact factor: 1.764

Review 2.  Spinal Solitary Fibrous Tumors: An Original Multicenter Series and Systematic Review of Presentation, Management, and Prognosis.

Authors:  Caroline Apra; Amira El Arbi; Anne-Sophie Montero; Fabrice Parker; Steven Knafo
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

3.  Solitary fibrous tumour of the spine: imaging features of a commonly misdiagnosed entity.

Authors:  Ning Lang; Enlong Zhang; Xiaoying Xing; Huishu Yuan
Journal:  Eur Radiol       Date:  2018-04-04       Impact factor: 5.315

4.  Solitary fibrous tumor of the lumbar spine: the great mimicker-report of the fifth case.

Authors:  Amer Sebaaly; Lara Raffoul; Ronald Moussa
Journal:  Case Rep Orthop       Date:  2014-07-09

5.  Recurrent solitary fibrous tumor of lumbar spine with vertebral body involvement: imaging features and differential diagnosis with report of a case.

Authors:  Zerwa Farooq; Zain Badar; Daniel Zaccarini; Felix B Tavernier; Anthony Mohamed; Rajiv Mangla
Journal:  Radiol Case Rep       Date:  2016-09-20

6.  Spinal Intramedullary Solitary Fibrous Tumor: A Rare and Challenging Diagnosis.

Authors:  Chenlong Yang; Yulun Xu; Xiaoguang Liu
Journal:  Cancer Manag Res       Date:  2019-12-10       Impact factor: 3.989

7.  A cervical solitary fibrous tumor with intramedullary invasion.

Authors:  Andrea Ciuffi; Christian Saleh; Maria Rosa Terreni; Phillip Jaszczuk; Edvin Zekaj; Claudia Menghetti; Andrea Franzini; Domenico Servello
Journal:  Surg Neurol Int       Date:  2022-08-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.